AAAAAA

   
Results: 1-8 |
Results: 8
Loss of functional capacity caused by a delayed onset of DMARD therapy in rheumatoid arthritis. Long-term follow-up results of the Keitel function test - Brief definite report
Authors: Keysser, M Keysser, C Keitel, W Keysser, G
Citation: M. Keysser et al., Loss of functional capacity caused by a delayed onset of DMARD therapy in rheumatoid arthritis. Long-term follow-up results of the Keitel function test - Brief definite report, Z RHEUMATOL, 60(2), 2001, pp. 69-73
Actual use of statins at hospital discharge after acute myocardial infarction
Authors: Wienbergen, H Schiele, R Gitt, AK Schneider, S Heer, T Gohlke, H Gottwik, M Thiele, M Thiele, R Keysser, M Horsch, A Weizel, A Senges, J
Citation: H. Wienbergen et al., Actual use of statins at hospital discharge after acute myocardial infarction, Z KARDIOL, 90(6), 2001, pp. 394-400
Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation
Authors: Hou, WS Li, ZQ Gordon, RE Chan, K Klein, MJ Levy, R Keysser, M Keyszer, G Bromme, D
Citation: Ws. Hou et al., Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation, AM J PATH, 159(6), 2001, pp. 2167-2177
Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: Evaluation of 602 sessions of extracorporeal immunoadsorption
Authors: Matic, G Hofmann, D Winkler, R Tiess, M Michelsen, A Schneidewind, JM Hebestreit, G Keysser, M Muller, W Kinze, EM Ramlow, W
Citation: G. Matic et al., Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: Evaluation of 602 sessions of extracorporeal immunoadsorption, ARTIF ORGAN, 24(2), 2000, pp. 103-107
Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: Results of an observational study with matched-pair analysis
Authors: Keyszer, G Keysser, C Keysser, M
Citation: G. Keyszer et al., Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: Results of an observational study with matched-pair analysis, CLIN RHEUMA, 18(2), 1999, pp. 145-151
Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA)
Authors: Keysser, M Keysser, G Keysser, C
Citation: M. Keysser et al., Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA), Z RHEUMATOL, 58(5), 1999, pp. 267-276
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers
Authors: Keyszer, G Lambiri, I Nagel, R Keysser, C Keysser, M Gromnica-Ihle, E Franz, J Burmester, GR Jung, K
Citation: G. Keyszer et al., Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers, J RHEUMATOL, 26(2), 1999, pp. 251-258
Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity
Authors: Keyszer, G Lambiri, I Keysser, M Keysser, C Nagel, R Burmester, GR Jung, K
Citation: G. Keyszer et al., Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity, Z RHEUMATOL, 57(6), 1998, pp. 392-398
Risultati: 1-8 |